Bristol-Myers, Consumers Look To Centralize NJ Abilify Suits
Bristol-Myers Squibb Co., Otsuka America Pharmaceutical Inc. and consumers of the companies' antipsychotic drug Abilify have urged a New Jersey state court to grant multi-county litigation status to at least 42...To view the full article, register now.
Already a subscriber? Click here to view full article